Bing Chen
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 16
- Protein Degradation and Inhibitors 16
- Circular RNAs in diseases 12
- RNA Research and Splicing 11
- Hematology 45
- Multiple Myeloma Research and Treatments 31
- Co-authors
- Shenglin Huang (5 shared papers)Xianghuo He (5 shared papers)Yuchen Li (4 shared papers)Jingjing Zhao (3 shared papers)Shengli Li (2 shared papers)Peng Wang (2 shared papers)Qiupeng Zheng (2 shared papers)Yan Li (1 shared paper)
- Journals
- Blood (9 papers)PLoS ONE (4 papers)Frontiers in Immunology (3 papers)OncoTargets and Therapy (3 papers)BMC Cancer (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bing Chen
138 papers receiving 3.1k citations
Bing Chen's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 1.2k
- Molecular Biology 2.0k
- Geriatrics and Gerontology 95
- Hematology 213
- Immunology 375
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes Hit paper breakdown → | 2017 | 422 |
| 2 | 2018 | 249 | |
| 3 | 2017 | 158 | |
| 4 | 2000 | 128 | |
| 5 | 1999 | 125 | |
| 6 | 2015 | 124 | |
| 7 | 2020 | 105 | |
| 8 | 2021 | 100 | |
| 9 | 2017 | 68 | |
| 10 | 2019 | 66 | |
| 11 | 2012 | 66 | |
| 12 | 2006 | 48 | |
| 13 | 2019 | 46 | |
| 14 | 2019 | 43 | |
| 15 | 2013 | 43 | |
| 16 | 2020 | 40 | |
| 17 | 2020 | 35 | |
| 18 | 2021 | 33 | |
| 19 | 2023 | 32 | |
| 20 | 2020 | 32 |
About Bing Chen
Bing Chen is a scholar working on Molecular Biology, Hematology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 151 papers that have together received 3.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (16 papers), Protein Degradation and Inhibitors (16 papers), Peptidase Inhibition and Analysis (16 papers), Circular RNAs in diseases (12 papers), RNA Research and Splicing (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.0k citations), Geriatrics and Gerontology (95 citations), Hematology (213 citations) and Immunology (375 citations). Bing Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shenglin Huang, Xianghuo He, Yuchen Li, Jingjing Zhao, Shengli Li, Peng Wang, Qiupeng Zheng, Yan Li, Yan Tang and Shulin Yu. Their work appears in journals such as Blood, PLoS ONE, Frontiers in Immunology, OncoTargets and Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.